Redmile Group »

Establishment Labs Holdings Ord shares owned by Redmile Group

Quarter-by-quarter ownership of Establishment Labs Holdings Ord (ESTA) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Establishment Labs Holdings Ord

Tip: Access up to 7 years of quarterly data

All positions including Establishment Labs Holdings Ord held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Establishment Labs Holdings Ord by Redmile Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.8M 114k 50.90
2019-09-30 $189k 10k 18.90
2019-06-30 $220k 10k 22.00
2019-03-31 $3.4M 142k 24.04
2018-12-31 $3.9M 142k 27.42
2018-09-30 $3.6M 150k 24.10

More positions owned by Redmile Group

Krystal Biotech (KRYS)
Amicus Therapeutics (FOLD)
Immunome (IMNM)
Scholar Rock Hldg Corp (SRRK)
Fate Therapeutics (FATE)
Regenxbio Inc equity us cm (RGNX)
Deciphera Pharmaceuticals (DCPH)
Kymera Therapeutics (KYMR)
Adc Therapeutics Sa SHS (ADCT)
Stoke Therapeutics (STOK)
Augmedix (AUGX)
Nurix Therapeutics (NRIX)
Biohaven (BHVN)
Beam Therapeutics (BEAM)
Zymeworks Del (ZYME)

View all positions for Redmile Group

Top funds holding Establishment Labs Holdings Ord

JW Asset Management
Nantahala Capital Management
Brown Advisory Holdings Incorporated
Jpmorgan Chase & Co
Cowen And Company
Findell Capital Management
Citadel Advisors
Rice Hall James & Associates
Morgan Stanley
Point72 Asset Management
Bamco
William Blair Investment Management
Adage Capital Partners GP
Kornitzer Capital Management
Citigroup

View all funds holding Establishment Labs Holdings Ord